Castle Biosciences Investor Relations Material

Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Castle Biosciences is a provider of products that assesses the response of cancer patients to treatment. The company's products include Immunoscore non-invasive test, which measures changes in proteins expressed on the surface of a person's tumor; CastleTRAC, a diagnostic tool for assessing the tissue response in four types of cutaneous T-cell lymphomas (CTCL); and CastleMAP for measuring the immune reaction to a specific drug. Castle Biosciences, Inc., is based in Friendswood, Texas.